ZEO ScientifiX selected as qualified team for XPRIZE Healthspan $101M competition semi-finals

Zeo ScientifiX, Inc.

Advancing to semi-finals of XPRIZE Healthspan; aims to develop therapeutics restoring muscle, cognitive, and immune function by 10-20 years in persons aged 65-80.
Assembled multidisciplinary team: Dr. Shapiro (CMO), Elizabeth Parrish (BioViva), Dr. Andrews (telomere biology), Dr. Kennedy (Buck Institute), and others.
Focus on extracellular vesicle (exosome) therapeutics and next-generation delivery systems targeting aging and inflammation biology.
Company operates labs at Nova Southeastern University; recently appointed as A4M regenerative medicine educational partner.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.